-
3m 45sPart 1 | Session 2 The Volt CE Mark Study
-
5m 34sPart 1 | Session 3 Optimizing Antimicrobial Strategies for CIED-Related Infections
-
6m 37sPart 1 | Session 4 Patient Selection for Conduction System Pacing
-
4m 22s
-
4m 24sPart 1 | Session 6 SINGLE SHOT CHAMPION: PFA Vs Cryoballoon Ablation for PAF
-
4m 55sPart 1 | Session 7 3-Year Outcomes from SWISS-APERO
-
4m 33sPart 1 | Session 8 CONSIDERING-AF: DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for AF
-
3m
-
3m 9sPart 1 | Session 10 The SwissTAVI Registry: Pacemaker Implantation After TAVI
-
8m 56sPart 2 | Session 1 Key Takeaways from the EHRA Ablation Innovation Summit 2025
-
5m 53sPart 2 | Session 2 Highlights with Dr Dominik Linz
-
2m 53sPart 2 | Session 3 4 Trials That Will Change My Practice with Dr Luigi Di Biase
EHRA 2025 - We are joined onsite at EHRA Congress 2025 by Prof Pier Lambiase to discuss the latest developments in ventricular tachycardia substrate identification from the EHRA Ablation Summit 2025.
Interview Questions:
1. What are the key challenges or limitations that still exist in accurately identifying VT substrates?
2. What are the most significant recent advancements in techniques or technologies for identifying VT substrates, and how do they improve upon previous methods?
3. How are these new insights into VT substrate identification influencing current clinical practices in the management and treatment of VT?
4. How do these advancements in VT substrate identification directly benefit patients, particularly in terms of treatment outcomes and quality of life?
5. What are the most promising areas of research or development in VT substrate identification, and how might they shape the future of arrhythmia management?
Recorded Onsite at EHRA Congress 2025, Vienna.
Editors: Jordan Rance and Yazmin Sadik
Video Specialists: Tom Green, Oliver Miles
Watch our video collection covering late-breaking data from EHRA Congress 2025 for short, accessible Expert Interviews and Highlights of the most pertinent trials.
More from this programme
Faculty Biographies
Pier D Lambiase
Consultant Cardiologist
Prof Pier Lambiase, PhD, FRCP, BMBCh, is a consultant cardiologist specialising in the treatment of heart rhythm disorders and pacemaker implantation. He graduated from Oxford University in 1992 and trained in cardiology at St Thomas’ and Hammersmith Hospitals. Following completion of a PhD in 2002, he undertook higher specialist training in electrophysiology and became a consultant cardiologist and senior lecturer at the Heart Hospital, UCL in 2006 and was promoted to reader in cardiology in 2012.
He was the British Cardiac Society Young Investigator in 2002 and finalist in the North American Pacing & Electrophysiology Society Young Investigator competition in the same year. He was awarded the British Cardiovascular Society Early Career Award for his research in 2015 and elected Fellow of the Heart Rhythm Society the same year.
Prof Lambiase conducts research into the causes and treatment of inherited rhythm disturbances, sudden arrhythmic death…
Comments